There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...

Boston Scientific will acquire Axonics for about $3.7 billion in cash. The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. By way of example, Axonics (NASDAQ:AXNX) has seen its share price ...

Boston Scientific Corporation (NYSE:BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $71 in cash per share, representing an enterprise value of approximately $3.4 billion and an equity value ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...

Ladies and gentlemen, thank you for standing by and welcome to the Axonics Q3 2019 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation ...

Axonics Modulation Technologies Inc. (Nasdaq: AXNX) of Irvine said the U.S. Patent and Trademark Office’s decision to review six of seven patent claims from competitor Medtronic PLC (NYSE: MDT) on ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...